The Platform

RENO
Biologics

Four biological categories. Each serving a distinct and irreplaceable role. Select a category to explore the full product line.

I
Vesicle-Mediated Signalling

Exosomes

Membrane-bound extracellular vesicles derived from human umbilical cord. Exosomes carry protected biological information — growth factors, signalling proteins, and intercellular communication — in a form the body recognises as its own. They restore signals the body once produced in abundance and has progressively lost over time.
EXO-30
Consumer & Clinical
Wharton's Jelly · Topical
Concentration30B exosomes
Volume5mL
FormatLyophilised
ReconstitutionCopper Peptide Solution
Wharton's jelly–derived exosomes with collagen peptides. The surface-oriented formulation — configured specifically for skin rejuvenation, hair restoration, and topical tissue repair. Reconstituted with copper peptide solution for enhanced delivery.
Shop EXO-30
EXO-50
Consumer & Clinical
Wharton's Jelly · Topical & Systemic
Concentration50B exosomes
Volume5mL
FormatLyophilised
ReconstitutionCopper Peptide Solution
Wharton's jelly–derived exosomes for both topical and systemic applications. The foundational Wharton's jelly systemic formulation — used across regenerative aesthetics and musculoskeletal protocols. Reconstituted with copper peptide solution.
Shop EXO-50
EXO-90
Consumer & Clinical
Endothelial · Systemic
Concentration90B exosomes
Volume1mL
FormatLyophilised
SourceEndothelial Stem Cell
Endothelial stem cell–derived exosomes for systemic administration. Carries the biological language of circulation — vascular interface communication, immune modulation, and neurovascular signalling. The foundational longevity and healthspan formulation.
Shop EXO-90
EXO-180
Clinical Only
Endothelial · Advanced Systemic
Concentration180B exosomes
Volume1mL
FormatCryopreserved
SourceEndothelial Stem Cell
The apex endothelial formulation. Cryopreserved for maximum biological integrity. Advanced clinical systemic applications — organ-level regenerative support, advanced longevity protocols, and the full biological environment protocol alongside WJ-300 and CM-2.
Apply for Clinical Access
II
Structural Matrix · Clinical Only

Wharton's Jelly

The connective tissue matrix of the umbilical cord. Rich in hyaluronic acid, collagen, proteoglycans, and the structural proteins that define connective tissue architecture. Wharton's Jelly restores the extracellular environment — the physical space in which cellular activity occurs. All formulations are clinical use only.
WJ-75
Clinical Only
Structural · Broad Distribution
Concentration75mg
Volume3mL
FormatFrozen
Frozen Wharton's jelly for broad surface distribution. Lower density larger area applications — indicated for surface-level structural support in regenerative aesthetic contexts alongside EXO-30 or EXO-50.
Apply for Clinical Access
WJ-95
Clinical Only
Concentrated · Small Joints
Concentration95mg
FormatLyophilised
Lyophilised Wharton's jelly for concentrated placement in smaller joint environments. The primary small joint musculoskeletal formulation — typically paired with EXO-50 for complete structural and signalling support.
Apply for Clinical Access
WJ-150
Clinical Only
High Density · Structural Joints
Concentration150mg
Volume1mL
FormatFrozen
Frozen Wharton's jelly for high density targeted placement in structural joint applications. Paired with EXO-180 for advanced systemic signalling into the restored structural environment.
Apply for Clinical Access
WJ-300
Clinical Only
Maximum Volume · Expanded Environments
Concentration300mg
Volume2mL
FormatFrozen
Maximum volume Wharton's jelly for expanded joint and tissue environments. The cornerstone of the full biological environment protocol — paired with EXO-90 and CM-1, or EXO-180 for advanced applications.
Apply for Clinical Access
III
Soluble Signal Environment · Clinical Only

Conditioned Media

The soluble secretome — the full spectrum of growth factors, cytokines, and signalling proteins secreted by umbilical cord stem cells. Conditioned media provides immediate ambient factor availability, filling the biological space the moment treatment is delivered. Clinical use only.
CM-1
Clinical Only
Baseline Soluble Signal Environment
Volume1mL
FormatLiquid Frozen
Signal TypeSoluble · Non-vesicular
Baseline conditioned media providing immediate broad soluble signal availability. The ambient factor component of the full biological environment protocol — paired with WJ-300 and EXO-90 for complete structural, sustained, and immediate signalling coverage.
Apply for Clinical Access
CM-2
Clinical Only
Expanded Soluble Signal Environment
Volume2mL
FormatLiquid Frozen
Signal TypeSoluble · Non-vesicular
Expanded conditioned media for larger tissue area exposure and greater soluble signal reach. The longevity protocol component — paired with EXO-180 to produce the most complete systemic regenerative environment available within the RENOVÓ platform.
Apply for Clinical Access
IV
Clinical Optimisation Portfolio · Clinical Partners Only

Peptides

A comprehensive clinical peptide portfolio curated for verified RENOVÓ partner practices. US manufactured to a minimum 99% purity standard with Certificate of Analysis documentation on every batch. Available exclusively to approved clinical partners.
I
Tissue Repair & Recovery
Peptides targeting accelerated tissue healing, wound repair, tendon and ligament recovery, and post-surgical regeneration. Integrated alongside Wharton's jelly and exosome protocols for musculoskeletal applications.
II
Metabolic & Weight
Peptides for metabolic optimisation and weight regulation. The RENOVÓ weight management protocol incorporates Retatrutide as the foundation with SS-31 or MOTS-c as energy enhancement components.
III
Cognitive & Neurological
Peptides supporting cognitive function, neurological health, and neurovascular signalling. Integrated alongside EXO-90 and EXO-180 for comprehensive systemic neurological support protocols.
IV
Immune Modulation
Peptides for immune system regulation and inflammatory modulation. Particularly relevant in chronic inflammatory conditions and post-recovery protocols requiring immune environment optimisation.
V
Hormonal Balance
Peptides addressing hormonal regulation and endocrine support. Integrated into longevity and healthspan protocols where hormonal environment is identified as a contributing factor to biological performance.
VI
Sleep Optimisation
Peptides targeting sleep quality, recovery depth, and circadian regulation. Sleep environment quality is a fundamental determinant of biological regeneration — addressed directly within comprehensive longevity protocols.
Access the Full Peptide Portfolio
The complete RENOVÓ peptide portfolio is available to verified clinical partners only. Apply for a clinical account to access the full catalogue, clinical pricing, and direct support.
Apply for Clinical Access